Search
CureVac NV
CVACAdd to Watchlist
4.660USD
0.0000.00%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
1.05BMarket Cap
9.59P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-01-05The current earnings forecast score of CureVac NV is 6.40, ranking 340 out of 401 in the Biotechnology & Medical Research industry. The average price target is 5.46, with a high of 5.50 and a low of 2.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is CureVac NV's expected revenue for the next quarter?
CureVac NV's expected revenue is 11.39M.
What is CureVac NV's price target?
Analysts forecast that CureVac NV's price target is USD 5.46, with the highest forecast at USD 5.50 and the lowest forecast at USD 2.00.
How have CureVac NVCVAC's recent earnings per share performed?
The market expectation was USD 1.42, while CureVac NVCVAC's earnings per share (EPS) for the previous quarter was USD -0.31. EPS for the next quarter is expected at USD -0.08.
